Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. - Wikidata - awgldk - TriplyDB

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

http://www.wikidata.org/entity/Q33551239

about

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Circulating tumor cells in breast cancer Minimal residual disease and circulating tumor cells in breast cancer Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.Towards Engineered Processes for Sequencing-Based Analysis of Single Circulating Tumor Cells Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Accurate detection of carcinoma cells by use of a cell microarray chip CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in Epithelial to Mesenchymal Transition KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.CTC enumeration and characterization: moving toward personalized medicine.EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.Clinical relevance and biology of circulating tumor cells.An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.Sensitive and direct detection of circulating tumor cells by multimarker µ-nuclear magnetic resonance.Deformability of Tumor Cells versus Blood Cells.The potential for liquid biopsies in the precision medical treatment of breast cancer.The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancer Versatile immunomagnetic nanocarrier platform for capturing cancer cells.Breast Cancer Biomarkers: Utility in Clinical Practice.Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.Circulating tumor cells as emerging tumor biomarkers in breast cancer.Plasticity of disseminating cancer cells in patients with epithelial malignancies.Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.Enrichment, detection and clinical significance of circulating tumor cells.Overview of current standpoints in profiling of circulating tumor cells.Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients Application of an improved magnetic immunosorbent in an Ephesia chip designed for circulating tumor cell capture.Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer.mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker.CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion.Nestin and cluster of differentiation 146 expression in breast cancer: Predicting early recurrence by targeting metastasis?Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia.Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.

P2860

Q26748850-A8AD7CC9-2E59-4DFE-9F11-2F31A4D47D67 Q26774808-9FAC1A4B-8A25-41BE-A7C6-2B9001ABFB70 Q27010152-1D459D9B-CDE3-4F70-ACDB-C17AF76B3CA5 Q27024191-E7355445-008F-42A1-BB22-9E3416082AD3 Q30445250-437DB57B-34C9-4158-A3F8-3DA14E7EF81D Q33604017-81A25365-94B0-4707-8A99-8762BDD6EF9B Q33721117-D61B26DA-D129-48E8-ABCB-551CFB14BDA3 Q33820233-495DE114-90C2-4B58-9943-557284A50398 Q34187178-75A8E6F9-E897-4DF4-807F-0964CEEDF95D Q34405536-A3100268-882A-4F27-8E5B-373FC3BA05FF Q34509268-D83E0701-07F7-4695-B373-8EE263B22C75 Q34577724-4719D808-9FAE-4816-8D99-67B1955351B0 Q35875956-C90E8C7C-5EEA-4DCE-A37B-17C68A3E19CB Q35889548-4C9081D6-D042-43DD-BC31-A60756EB73E9 Q35927942-61A4B70B-EA9A-43DE-B296-DFC3332635B1 Q35951699-3DC8F951-3303-4EB1-9124-F12AA340477B Q36062143-C1F7B5D8-9EFA-4EA8-92F6-9154207849B5 Q36382613-825CA8C6-1A58-429A-BC0A-7D3B32066BB3 Q36849660-C6590E09-482A-4F68-B9B8-B5E07BA7FF6F Q37215538-2217E05F-8732-4A45-B925-83AFDA5C6500 Q37320837-8645427F-C7D5-4B84-8C79-75F0FDF5F181 Q37355506-6F55B57A-F0C9-4F78-808F-BABE61CD2422 Q37441159-27035D72-69E1-4911-82A1-B53F2BCB8586 Q37894736-870D9831-53EC-4DF1-8B6E-D71D8D39FB0D Q37908134-E11FC08A-89A2-4F83-ACCB-806E1039C30C Q38021683-6B185639-3411-429B-A4BF-708F36674C29 Q38097525-C52F57DE-ABFD-471B-BC7C-138F256F28C1 Q38102590-6A492FCE-8D31-453A-9F33-9EA14C8B4AF9 Q38161450-6737B4F8-2059-4E39-96D6-14E21C5FECF9 Q38925555-911FA8DD-C183-4C6A-A2DC-4CF6B0104ECD Q39123704-F5F66FBC-19DC-417D-9AF2-71B8E4AC0E04 Q39339880-19AD3303-357D-444F-8D9A-EE85B8546686 Q39385781-6AAAAB66-E84E-4C33-8E0A-7A6FAB3395CF Q41035419-8707A8BE-7F63-455A-96D3-293E00E7AC81 Q41136311-599D411F-0176-459D-B6DC-9C07AB9DCBA3 Q42242553-57C271FB-1B77-4F45-B5E5-14013C98FE82 Q46213211-E13CE57A-E438-44A6-9D58-67BCD7C01FD9 Q47409033-A0F8548D-FEBD-4DC8-BD6D-6ACA1E9499D2 Q49023149-7C339456-CE60-41C6-9287-CDEA324F07A0 Q50090313-4245F8A3-6121-456D-AD7E-C86B8E64D5BF

P2860

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

http://www.wikidata.org/entity/Q33551239

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@ast

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@en

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@nl

type

label

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@ast

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@en

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@nl

prefLabel

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@ast

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@en

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@nl

P1433

Q33551239-279850C9-8B2B-4174-A870-E4C4837AB7D6

P1476

Q33551239-6D51612B-8436-4C5E-9F28-819AC3A77AFA

P2093

Q33551239-00F269CF-219E-4564-8489-440F7978CAF4

Q33551239-34289C7C-305B-4CA4-BA0D-652AA812BD21

Q33551239-4A731C10-7F1D-4817-80E1-D31A20301E70

Q33551239-79C3A281-F317-41DC-9407-A001E359807C

Q33551239-7F620611-6FF6-4BDB-A766-C9960E5C87AE

Q33551239-7FD7CEDD-982E-44E0-9322-81C9E50CD1DE

Q33551239-900E9107-0215-4116-A35D-9331C5E14B4F

Q33551239-B4BC743C-9A11-40D4-8D21-671C78BED062

Q33551239-CD2FCE32-98EE-4327-90ED-58C291068220

Q33551239-E36ED477-D17E-40C3-B3E4-E23B9BD81B3F

P2860

Q33551239-15F670BA-07E2-4495-9E28-DD039DE31275

Q33551239-1BBD6E27-2579-4EC3-8AAB-58F3FF0FE381

Q33551239-2692FD07-ECBB-4D97-8A38-935943AF509E

Q33551239-2DB0CC0F-8536-4742-A8BA-F060874743BC

Q33551239-4365E478-8EE7-4A86-9ED9-59A417518325

Q33551239-4DCE5AC8-0C9B-4B4D-A97A-3C46E2B8C993

Q33551239-6A3D1B94-4023-4E7A-959E-7263212605E3

Q33551239-6EBE5406-190A-413F-BC66-EAB983F61B17

Q33551239-734A6BEF-B776-455C-B570-E5F6A0832E4B

Q33551239-8005E91C-6706-49A9-874F-71AB8ABCC8CE

P2888

Q33551239-17B16E60-FA70-4348-9157-35DADB62E989

P304

Q33551239-23FC8193-D3AC-4714-936A-327A50DFFCAD

P31

Q33551239-2319882F-BA05-4169-AA91-D95C66E17F8B

P356

Q33551239-F6B1199D-BFDE-4E75-8C3A-8F4D5A5610F1

P407

Q33551239-FAF12DFD-0F25-4983-A3EB-44FAF3EAF0BE

P433

Q33551239-BFFD5B5D-C03A-4059-AB39-247B1133355D

P478

Q33551239-225CC7A9-7C1F-4D04-8B0F-AE9FB98AF968

P50

Q33551239-04CD8C39-A518-4F20-8E35-069DC9C5D122

P577

Q33551239-BE7024BC-9E18-4682-A591-1D6275B01262

P5875

Q33551239-C8FD67DC-54F8-4C5F-881B-03E39665A063

P6179

Q33551239-6B4F5CE2-3698-41AF-B85F-A17E2B1971DE

P698

Q33551239-7156DE52-7F9E-49FC-A970-1C14567971C3

P356

S10549-010-0879-Y

P1433

Breast Cancer Research and Treatment

P1476

Detection of circulating tumor ...... gh enrichment with anti-CD146.

@en

P2093

Anieta M Sieuwerts

http://www.w3.org/2001/XMLSchema#string

Annemieke M Timmermans

http://www.w3.org/2001/XMLSchema#string

Bianca Mostert

http://www.w3.org/2001/XMLSchema#string

Jan-Willem Gratama

http://www.w3.org/2001/XMLSchema#string

Joan Bolt-de Vries

http://www.w3.org/2001/XMLSchema#string

John A Foekens

http://www.w3.org/2001/XMLSchema#string

John W M Martens

http://www.w3.org/2001/XMLSchema#string

Mieke Schutte

http://www.w3.org/2001/XMLSchema#string

Petra van der Spoel

http://www.w3.org/2001/XMLSchema#string

Renée Foekens

http://www.w3.org/2001/XMLSchema#string

P2860

A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines

Molecular portraits of human breast tumours

Systematic variation in gene expression patterns in human cancer cell lines

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Circulating tumour cell detection on its way to routine diagnostic implementation?

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

The prognostic implications of circulating tumor cells in patients with breast cancer.

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

Circulating endothelial cells in oncology: pitfalls and promises

P2888

s10549-010-0879-y

P304

33-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-010-0879-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43081102

http://www.w3.org/2001/XMLSchema#string

P6179

1038223123

http://www.w3.org/2001/XMLSchema#string

P698

20379845

http://www.w3.org/2001/XMLSchema#string